CalciMedica
CALC
22 hedge funds and large institutions have $188M invested in CalciMedica in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
73.76% more ownership
Funds ownership: 0% → 73.76% (+74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
+$78.7M |
| 2 |
OrbiMed
New York
|
+$66.7M |
| 3 |
Blackstone Inc
New York
|
+$28.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.81M |
Top Sellers
CALC Hedge Fund Activity: Q3 2020 in Review
22 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2020, worth a combined $188M.
Buyers outnumbered sellers: 22 funds opened new CALC positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $78.7M.
- 22 institutional investors held CalciMedica (CALC) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $188M of CalciMedica stock for Q3 2020.
- 22 funds opened new CalciMedica positions in Q3 2020 and 0 closed out, a net change of +22 holders.
- The largest CalciMedica buyer in Q3 2020 was Deerfield Management, an estimated $78.7M added.
Based on aggregated 13F filings for Q3 2020.